Perhaps, in-depth cell-specific transcriptomic investigation will guide better understanding of cellular impact and underlying mechanisms of the IL-4 and IL-18 signaling pathways, and then lead to better drug targets for AD treatment. Here, IL4 is linked to Alzheimer disease.